Last update 22 Feb 2025

EGFRvIII Targeted CAR-T-UCSF(San Francisco Conservatory of Music/University of California)

Overview

Basic Info

Drug Type
CAR-T
Synonyms-
Target
EGFRvIII
Mechanism
EGFRvIII antagonists(Epidermal growth factor receptor variant III antagonists)
Therapeutic Areas
NeoplasmsNervous System DiseasesOther Diseases
Active Indication-
Inactive Indication
Glioblastoma
Originator Organization
San Francisco Conservatory of MusicSan Francisco Conservatory of MusicUniversity of California, Santa BarbaraUniversity of California, Santa Barbara
Active Organization-
Inactive Organization
San Francisco Conservatory of MusicSan Francisco Conservatory of MusicUniversity of California, Santa BarbaraUniversity of California, Santa Barbara
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with EGFRvIII Targeted CAR-T-UCSF(San Francisco Conservatory of Music/University of California)
Login to view more data
100 Translational Medicine associated with EGFRvIII Targeted CAR-T-UCSF(San Francisco Conservatory of Music/University of California)
Login to view more data
100 Patents (Medical) associated with EGFRvIII Targeted CAR-T-UCSF(San Francisco Conservatory of Music/University of California)
Login to view more data
1
Literatures (Medical) associated with EGFRvIII Targeted CAR-T-UCSF(San Francisco Conservatory of Music/University of California)
28 Apr 2021Science translational medicineQ1 · MEDICINE
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma
Q1 · MEDICINE
100 Deals associated with EGFRvIII Targeted CAR-T-UCSF(San Francisco Conservatory of Music/University of California)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
GlioblastomaPreclinical
US
San Francisco Conservatory of MusicSan Francisco Conservatory of Music
28 Apr 2021
GlioblastomaPreclinical
US
University of California, Santa BarbaraUniversity of California, Santa Barbara
28 Apr 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free